Healthcare Triangle Faces Nasdaq Delisting Notice

Healthcare Triangle ( (HCTI) ) has issued an update.

On May 20, 2025, Healthcare Triangle, Inc. received a notification from Nasdaq regarding the potential delisting of its securities due to concerns over substantial dilution from its private placement of Series A and B Warrants. The company has been given until May 30, 2025, to address these concerns with a compliance plan and is considering trading on the OTCQB market as an alternative if delisting occurs.

Spark’s Take on HCTI Stock

According to Spark, TipRanks’ AI Analyst, HCTI is a Underperform.

Healthcare Triangle is currently in a challenging financial position with negative revenue growth, persistent losses, and negative equity. The technical analysis further highlights a bearish trend, with the stock trading below key moving averages. Valuation metrics are poor, with a negative P/E ratio and no dividend yield. While the new CFO appointment is a positive corporate event, it is not sufficient to offset the overall negative outlook.

To see Spark’s full report on HCTI stock, click here.

More about Healthcare Triangle

Healthcare Triangle, Inc. operates in the healthcare industry, focusing on providing technology solutions and services to enhance healthcare and life sciences organizations’ operational efficiency and patient care.

Average Trading Volume: 10,365,193

Technical Sentiment Signal: Sell

Current Market Cap: $2.7M

For a thorough assessment of HCTI stock, go to TipRanks’ Stock Analysis page.